Published in J Affect Disord on March 01, 1979
Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. BMJ (2004) 3.23
Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice. J R Coll Gen Pract (1988) 2.41
A randomised controlled trial to test the feasibility of a collaborative care model for the management of depression in older people. Br J Gen Pract (2007) 1.98
The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res (2000) 1.57
Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet (1993) 1.49
Violence, mental health, and physical symptoms in an academic internal medicine practice. J Gen Intern Med (2004) 1.45
The design, implementation and acceptability of an integrated intervention to address multiple behavioral and psychosocial risk factors among pregnant African American women. BMC Pregnancy Childbirth (2008) 1.35
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31
Response rates and selection problems, with emphasis on mental health variables and DNA sampling, in large population-based, cross-sectional and longitudinal studies of adolescents in Norway. BMC Public Health (2010) 1.19
Reducing psychosocial and behavioral pregnancy risk factors: results of a randomized clinical trial among high-risk pregnant african american women. Am J Public Health (2009) 1.16
Consumption of soft drinks and hyperactivity, mental distress, and conduct problems among adolescents in Oslo, Norway. Am J Public Health (2006) 1.16
Suicidal ideation and risk levels among primary care patients with uncomplicated depression. Ann Fam Med (2005) 1.11
"You always end up feeling like you're some hypochondriac": intimate partner violence survivors' experiences addressing depression and pain. J Gen Intern Med (2008) 1.00
Is relatively young age within a school year a risk factor for mental health problems and poor school performance? A population-based cross-sectional study of adolescents in Oslo, Norway. BMC Public Health (2005) 0.97
Problem-solving treatment and coping styles in primary care for minor depression. J Consult Clin Psychol (2008) 0.97
Risk behaviors of Filipino methamphetamine users in San Francisco: implications for prevention and treatment of drug use and HIV. Public Health Rep (2002) 0.97
Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Long-term symptoms of depression and anxiety in mothers of infants with congenital heart defects. J Pediatr Psychol (2010) 0.92
Differences in physical and mental health symptoms and mental health utilization associated with intimate-partner violence versus childhood abuse. Psychosomatics (2009) 0.91
Suicidal ideation, mental health problems, and social function in adolescents with eczema: a population-based study. J Invest Dermatol (2014) 0.90
Mental and somatic health complaints associated with school bullying between 10th and 12th grade students; results from cross sectional studies in Oslo, Norway. Clin Pract Epidemiol Ment Health (2009) 0.89
Trajectories of cigarette smoking from adolescence to young adulthood as predictors of obesity in the mid-30s. Nicotine Tob Res (2010) 0.87
Chronic medical problems and distressful thoughts of suicide in primary care patients: mitigating role of happiness. Int J Geriatr Psychiatry (2009) 0.86
An integrated randomized intervention to reduce behavioral and psychosocial risks: pregnancy and neonatal outcomes. Matern Child Health J (2012) 0.85
Predictors of mental distress among substance abusers receiving inpatient treatment. Subst Abuse Treat Prev Policy (2010) 0.82
Depression case management by practice nurses in primary care: an audit. Ment Health Fam Med (2008) 0.81
Pain complaints as risk factor for mental distress: a three-year follow-up study. Eur Child Adolesc Psychiatry (2011) 0.81
Reduction in mental distress among substance users receiving inpatient treatment. Int J Ment Health Syst (2010) 0.81
Understanding depressive symptoms among high-risk, pregnant, African-American women. Womens Health Issues (2011) 0.80
Bodily pain and associated mental distress among immigrant adolescents. A population-based cross-sectional study. Eur Child Adolesc Psychiatry (2005) 0.79
Own and parental war experience as a risk factor for mental health problems among adolescents with an immigrant background: results from a cross sectional study in Oslo, Norway. Clin Pract Epidemiol Ment Health (2006) 0.79
Treatment of traumatised refugees with basic body awareness therapy versus mixed physical activity as add-on treatment: Study protocol of a randomised controlled trial. Trials (2015) 0.78
Is the association between acne and mental distress influenced by diet? Results from a cross-sectional population study among 3775 late adolescents in Oslo, Norway. BMC Public Health (2009) 0.77
Feasibility study of an interactive multimedia electronic problem solving treatment program for depression: a preliminary uncontrolled trial. Behav Ther (2014) 0.76
Response: assessing the instruments. Addict Sci Clin Pract (2007) 0.76
Protocol for the atWork trial: a randomised controlled trial of a workplace intervention targeting subjective health complaints. BMC Public Health (2016) 0.75
Is there a negative impact of winter on mental distress and sleeping problems in the subarctic: the Tromsø Study. BMC Psychiatry (2012) 0.75
The mental health of populations directly and indirectly exposed to violent conflict in Indonesia. Confl Health (2010) 0.75
Transdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial. BMC Psychiatry (2017) 0.75
Which factors influence psychiatric diagnosing in substance abuse treatment? Int J Ment Health Syst (2013) 0.75
Expert Opinion-Depression in Patients with Heart Failure: Is Enough Being Done? Card Fail Rev (2016) 0.75
The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci (1974) 11.10
SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull (1973) 9.21
The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry (1974) 3.66
Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families. Neurology (1977) 1.97
A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia (1964) 1.79
Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr Scand (1973) 1.52
Neurotics who fail to take their drugs. Br J Psychiatry (1965) 1.44
The symptomatology and diagnosis of Gilles de la Tourette's syndrome. J Am Acad Child Psychiatry (1973) 1.29
The Hopkins Symptom Checklist. Assessing emotional distress in obstetric-gynecologic practice. Prim Care (1976) 1.27
Controlled study of pimozide vs. placebo in Tourette's syndrome. J Am Acad Child Psychiatry (1984) 1.26
Treatment of Tourette's syndrome with haloperidol, review of 34 cases. Arch Gen Psychiatry (1973) 1.25
Neurological features of Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry (1973) 1.22
Gilles de la Tourette's syndrome: summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes. Adv Neurol (1976) 1.20
An archaeal aminoacyl-tRNA synthetase missing from genomic analysis. J Bacteriol (1999) 1.16
Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia (1966) 1.12
Drug effects and initial severity of symptomatology. Psychopharmacologia (1965) 1.11
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry (1989) 1.09
The Hopkins Symptom Checklist (HSCL): factors derived from the HSCL-90 [proceedings]. Psychopharmacol Bull (1977) 1.09
Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. Arch Gen Psychiatry (1986) 0.98
Neurotic symptom dimensions. As perceived by psychiatrists and patients of various social classes. Arch Gen Psychiatry (1971) 0.97
Factors of symptom distress. Doctor ratings of anxious neurotic outpatients. Arch Gen Psychiatry (1969) 0.97
Influence of transfer RNA tertiary structure on aminoacylation efficiency by glutaminyl and cysteinyl-tRNA synthetases. J Mol Biol (2000) 0.93
An update on Tourette syndrome. Am J Psychother (1982) 0.93
Differentiating anxiety and depression in anxiety disorders: use of rating scales. Psychopharmacol Bull (1982) 0.93
Effects of informed consent on research patients a study results. J Nerv Ment Dis (1967) 0.93
Minor tranquilizers: clinical correlates of use in an urban population. Arch Gen Psychiatry (1978) 0.91
A follow-up of 78 patients with Gilles de la Tourette's syndrome. Am J Psychiatry (1976) 0.91
Drugs and group psychotherapy in neurotic depression. Am J Psychiatry (1974) 0.90
Birth, developmental, and family histories and demographic information in Tourette's syndrome. J Nerv Ment Dis (1972) 0.90
Treatment of Gilles de la Tourette syndrome with pimozide. Am J Psychiatry (1983) 0.89
Conservation of a tRNA core for aminoacylation. Nucleic Acids Res (1999) 0.89
Alternative design of a tRNA core for aminoacylation. J Mol Biol (2000) 0.88
Semantics of the placebo. Psychiatr Q (1968) 0.88
A tRNA circularization assay: evidence for the variation of the conformation of the CCA end. RNA (1998) 0.87
ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am J Psychiatry (1987) 0.87
Combined pharmacotherapy and psychotherapy. J Nerv Ment Dis (1969) 0.87
The use of placebos: a study of ethics and physicians' attitudes. Int J Psychiatry Med (1973) 0.86
Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients. Arch Gen Psychiatry (1986) 0.86
Placebo effects in psychotherapy and psychoanalysis. J Clin Pharmacol J New Drugs (1970) 0.85
The psychopathology of Gilles de la Tourette's syndrome. Am J Psychiatry (1972) 0.84
Symptomatic volunteers in multicenter drug trials. Prog Neuropsychopharmacol (1979) 0.84
Clonidine and haloperidol in Gilles de la Tourette syndrome. Arch Gen Psychiatry (1981) 0.84
Social class and race as mediator variables in neurotic symptomatology. Arch Gen Psychiatry (1971) 0.84
Diazepam: how much better than placebo? J Psychiatr Res (1983) 0.84
Defensiveness in the definition of placebo. Compr Psychiatry (1973) 0.84
Treatment of Gilles de la Tourette's Syndrome with haloperidol. Br J Psychiatry (1968) 0.84
Tourette syndrome: history and present status. Adv Neurol (1982) 0.84
Divergent adaptation of tRNA recognition by Methanococcus jannaschii prolyl-tRNA synthetase. J Biol Chem (2001) 0.84
Semiology, nosology and criteria for tic disorders. Rev Neurol (Paris) (1986) 0.83
Correlates of placebo reaction in an outpatient population. Psychol Med (1975) 0.83
Cognitive behavioral group psychotherapy combined with imipramine in major depression. Psychopharmacol Bull (1987) 0.82
Comparison of psychological symptoms between drug abusers seeking and not seeking treatment. J Nerv Ment Dis (1995) 0.82
Dimensions of outpatient neurotic pathology: comparison of a clinical vrsus an empirical assessment. J Consult Clin Psychol (1970) 0.82
Outpatient treatment of neurotic depression: medication and group psychotherapy. Proc Annu Meet Am Psychopathol Assoc (1976) 0.82
Abuse of an euphoretic combination. JAMA (1969) 0.81
Tic disorders. JAMA (1981) 0.81
Factorial invariance of symptom dimensions in anxious and depressive neuroses. Arch Gen Psychiatry (1972) 0.80
Organic factors in Gilles de la Tourette's syndrome. Br J Psychiatry (1973) 0.80
Subcategorizing Gilles de la Tourett's syndrome. Am J Psychiatry (1977) 0.80
Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes? J Neurol Neurosurg Psychiatry (1986) 0.80
Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of tourette syndrome. Adv Neurol (1982) 0.79
Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry (1974) 0.79
Symptom intensity and life stress in the city. Arch Gen Psychiatry (1974) 0.79
Effects of psychostimulants on aggression. J Nerv Ment Dis (1975) 0.78
Gilles de la Tourette's syndrome. Dangers of premature psychologic diagnosis. N Y State J Med (1970) 0.78
Effects of diphenylhydantoin on anxiety and hostility in institutionalized prisoners. Compr Psychiatry (1974) 0.78
Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Arch Gen Psychiatry (1983) 0.78
The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics (1979) 0.78
Study of the placebo effect with a self-administered placebo test. Compr Psychiatry (1974) 0.78
Seasonal changes in rule infractions among prisoners: a preliminary test of the temperature-aggression hypothesis. Psychol Rep (1993) 0.77
The validity of "identical matching placebos". Arch Gen Psychiatry (1974) 0.77
New concepts and treatments for anxiety. Md Med J (1986) 0.77
Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry (1981) 0.77
Enzyme activity in Tourette's syndrome. Arch Neurol (1984) 0.77
The reliability and validity of a placebo test. J Psychiatr Res (1979) 0.77
Clinical psychological testing in Tourette's syndrome. J Pers Assess (1974) 0.77
Eye-blink rate in Tourette's syndrome. J Nerv Ment Dis (1985) 0.77
Gilles de la Tourette's syndrome. Am Fam Physician (1974) 0.76
Pimozide-induced enuresis. Am J Psychiatry (1981) 0.76
Gilles de la Tourette's disease. Am J Psychiatry (1972) 0.76
Tourette's syndrome: summary of data on 34 patients. Psychosom Med (1975) 0.76
Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses. Psychopharmacologia (1970) 0.75
Dimensions of symptom distress in anxious neurotic outpatients. Psychopharmacol Bull (1969) 0.75